Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010 Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013
Trend and risk factors of drug resistance tuberculosis between 2005-2012 in Istanbul, Turkey Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004 Source: Eur Respir J 2010; 36: 584-593 Year: 2010
Treatment outcome and factors associated with unfavourable treatment results in cases with multidrug-resistant tuberculosis in Bulgaria for the period 2009-2010 Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Risk factors for drug-resistant tuberculosis patients in Lithuania, 2002–2008 Source: Eur Respir J 2012; 39: 1266-1269 Year: 2012
Treatment outcomes of MDR-TB patients notified in Romania during 2005-2007 Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013 Source: International Congress 2017 – MDRTB: detection and management Year: 2017
Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999 Source: Eur Respir J 2001; 18: Suppl. 33, 513s Year: 2001
Predisposing factors of multi drug resistant tuberculosis (MDR-TB) in Sardjito Hospital, Yogyakarta, Indonesia in 2009-2012 Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Adherence of drug-resistant tuberculosis patients to treatment in Tashkent, 2019-2020 Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021
Recurrence of tuberculosis into 2 years after new pulmonary TB cases curred. An observational study 2000-2005, Iasi, Romania Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008
Indicators of rifampicin-resistant TB response in Belarus, 2009-2014 Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Risk factors associated with MDR-TB deaths in Romania - 6 years retrospective study Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Fifteen years period (2000-2014) of resistant TB forms in Vojvodina (Serbia) Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Risk of mortality of extensively drug-resistant tuberculosis (XDR-TB) in Italy and Germany Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007
Our experience and treatment results of multidrug-resistant tuberculosis (MDR-TB) patients between 1996-2002 Source: Eur Respir J 2003; 22: Suppl. 45, 42s Year: 2003
TB mortality in Romania, 1999 Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001
Gender and other risk factors for multidrug-resistant (MDR) tuberculosis (TB) among migrants to Milan, Italy Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016
Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013